Viewing Study NCT00291967


Ignite Creation Date: 2025-12-25 @ 12:40 AM
Ignite Modification Date: 2025-12-25 @ 10:50 PM
Study NCT ID: NCT00291967
Status: COMPLETED
Last Update Posted: 2006-12-08
First Post: 2006-02-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Assess Immune Response Following Primary Vaccination With Tritanrix™-HepB Vaccine Mixed With 3 Formulations of Hib-MenAC Vaccine to Infants
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module